contraindications for glp-1 agonists include switching Table 5 from Glucagon-Like Peptide-1
Description
Specifically, semaglutide and tirzepatide, along with diet and exercise, are indicated for weight loss and have been shown to reduce body weight by up to 20%

As this is an activin-binding protein, increased follistatin levels result in the neutralization of more activin, which is capable of stimulating FSH secretion

11 While a number of different non-medication options exist for treatment of OSA, including lifestyle modifications, breathing devices, oral appliances, and surgical procedures, tirzepatide was approved by the FDA for moderate to severe obstructive sleep apnea in late 2024

Heres what sets us apart: Frequently Asked Questions What GLP-1 medications do you prescribe